Enovis ENOV
NYSE ENOV
$28.20 -0.35 (-1.23%)
As of: Nov 12, 2026 · 10:47 AM EST

Enovis (ENOV) Gains (Losses) on Sale of Assets & Investments (2018 - 2022)

Updated

Enovis (ENOV) reported Gains (Losses) on Sale of Assets & Investments of $30.3 million for Q4 2022, up 244.3% from the prior quarter.

Analysis

Enovis (ENOV) Gains (Losses) on Sale of Assets & Investments (2018 - 2022) Analysis & Trends

For FY2022, Enovis posted Gains (Losses) on Sale of Assets & Investments of $102.67 million.

  • By year, Gains (Losses) on Sale of Assets & Investments came in at -$10.13 million in FY2018.
  • Five-year quarterly Gains (Losses) on Sale of Assets & Investments spans a low of -$14.72 million in Q1 2018 and a high of $135.5 million in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 13.00 Mn
10 Enovis 1.63 Bn 1.54 Bn 339.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 30.30 Mn
Sep 30, 2022 8.80 Mn
Jul 1, 2022 135.50 Mn
Dec 31, 2018 -28,000.00
Jun 29, 2018 4.59 Mn
Mar 30, 2018 -14.72 Mn
API Access

Enovis Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ENOV&period=max&api_key=YOUR_API_KEY